These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12047009)

  • 1. Combination antipsychotics: pros, cons, and questions.
    Miller AL; Craig CS
    Schizophr Bull; 2002; 28(1):105-9. PubMed ID: 12047009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does adding a second antipsychotic to clozapine improve clinical response in resistant schizophrenia?
    Jiménez-Cornejo M; Munizaga G; Aceituno D
    Medwave; 2016 Dec; 16(Suppl5):e6614. PubMed ID: 27922589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotic combination therapy in schizophrenia. A review of efficacy and risks of current combinations.
    Freudenreich O; Goff DC
    Acta Psychiatr Scand; 2002 Nov; 106(5):323-30. PubMed ID: 12366465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When symptoms persist: clozapine augmentation strategies.
    Buckley P; Miller A; Olsen J; Garver D; Miller DD; Csernansky J
    Schizophr Bull; 2001; 27(4):615-28. PubMed ID: 11824488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antipsychotic drug combinations in the treatment of schizophrenia. A review of the literature].
    Gazdag G; Tolna J; Bitter I
    Neuropsychopharmacol Hung; 2012 Sep; 14(3):189-95. PubMed ID: 22987732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antipsychotic polypharmacy in high-utilising patients with schizophrenia].
    Schmidt-Kraepelin C; Puschner B; Loos S; Janssen B
    Psychiatr Prax; 2013 Oct; 40(7):380-4. PubMed ID: 23681790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine augmentation: safety and efficacy.
    Chong SA; Remington G
    Schizophr Bull; 2000; 26(2):421-40. PubMed ID: 10885641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of treatment resistant schizophrenia unresponsive to clozapine.
    Barnes TR; McEvedy CJ; Nelson HE
    Br J Psychiatry Suppl; 1996 Dec; (31):31-40. PubMed ID: 8968653
    [No Abstract]   [Full Text] [Related]  

  • 9. Clozapine-associated asterixis: case report.
    Kwak YT; Yang Y; Koo MS
    J Clin Psychopharmacol; 2014 Feb; 34(1):165-7. PubMed ID: 24158019
    [No Abstract]   [Full Text] [Related]  

  • 10. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
    Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Augmenting atypical antipsychotic medications with clozapin].
    Zink M; Dressing H
    Nervenarzt; 2005 Sep; 76(9):1092, 1094-8, 1100-2. PubMed ID: 15782324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of clozapine and amisulpride in treatment-resistant schizophrenia--case reports and review of the literature.
    Zink M; Knopf U; Henn FA; Thome J
    Pharmacopsychiatry; 2004 Jan; 37(1):26-31. PubMed ID: 14750045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient characteristics, burden and pharmacotherapy of treatment-resistant schizophrenia: results from a survey of 204 US psychiatrists.
    Correll CU; Brevig T; Brain C
    BMC Psychiatry; 2019 Nov; 19(1):362. PubMed ID: 31727015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined use of amisulpride and clozapine for patients with treatment-resistant schizophrenia.
    Cook B; Hoogenboom G
    Australas Psychiatry; 2004 Mar; 12(1):74-6. PubMed ID: 15715745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulpiride augmentation for schizophrenia.
    Wang J; Omori IM; Fenton M; Soares B
    Schizophr Bull; 2010 Mar; 36(2):229-30. PubMed ID: 20061345
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of lamotrigine augmentation of clozapine in a sample of treatment-resistant schizophrenic patients: a double-blind, placebo-controlled study.
    Zoccali R; Muscatello MR; Bruno A; Cambria R; Micò U; Spina E; Meduri M
    Schizophr Res; 2007 Jul; 93(1-3):109-16. PubMed ID: 17383857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can clinical practice guide a research agenda?
    Marder SR
    Schizophr Bull; 2002; 28(1):127-9. PubMed ID: 12047012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clozapine induced akathisia: a case report and review of the evidence.
    Grover S; Sahoo S
    Indian J Pharmacol; 2015; 47(2):234-5. PubMed ID: 25878393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schizophrenia past clozapine: what works?
    Mustafa FA
    J Clin Psychopharmacol; 2013 Feb; 33(1):63-8. PubMed ID: 23277242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials.
    Chakos M; Lieberman J; Hoffman E; Bradford D; Sheitman B
    Am J Psychiatry; 2001 Apr; 158(4):518-26. PubMed ID: 11282684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.